DrugPatentWatch Database Preview
Investigational Drug Information for GSK2982772
Email this page to a colleague
What is the drug development status for GSK2982772?
GSK2982772 is an investigational drug.
There have been 9 clinical trials for GSK2982772.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 15th 2016.
The most common disease conditions in clinical trials are Autoimmune Diseases, Psoriasis, and Colitis, Ulcerative. The leading clinical trial sponsors are GlaxoSmithKline, Quotient Clinical, and Quotient Sciences.
There are ten US patents protecting this investigational drug and one hundred and thirty-eight international patents.
Summary for GSK2982772
| US Patents | 10 |
| International Patents | 138 |
| US Patent Applications | 55 |
| WIPO Patent Applications | 14 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-11-15) |
| Vendors | 30 |
Recent Clinical Trials for GSK2982772
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants | GlaxoSmithKline | Phase 1 |
| A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772 | Quotient Sciences | Phase 1 |
| A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772 | GlaxoSmithKline | Phase 1 |
Clinical Trial Summary for GSK2982772
Top disease conditions for GSK2982772
Top clinical trial sponsors for GSK2982772
US Patents for GSK2982772
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| GSK2982772 | ⤷ Try it Free | Compounds, compositions and methods | Denali Therapeutics Inc. (South San Francisco, CA) | ⤷ Try it Free |
| GSK2982772 | ⤷ Try it Free | Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-- yl)-4H-1,2,4-triazole-3-carboxamide | GlaxoSmithKline Intellectual Property Development Limited (Brentford, Middlesex, GB) | ⤷ Try it Free |
| GSK2982772 | ⤷ Try it Free | Heterocyclic amides as kinase inhibitors | GlaxoSmithKline Intellectual Property Development Limited (Brentford, Middlesex, GB) | ⤷ Try it Free |
| GSK2982772 | ⤷ Try it Free | Compounds, compositions and methods | Denali Therapeutics Inc. (South San Francisco, CA) | ⤷ Try it Free |
| GSK2982772 | ⤷ Try it Free | Heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (Osaka-Shi, Osaka, JP) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for GSK2982772
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| GSK2982772 | Argentina | AR107537 | 2036-02-05 | ⤷ Try it Free |
| GSK2982772 | Argentina | AR115780 | 2036-02-05 | ⤷ Try it Free |
| GSK2982772 | Australia | AU2017213628 | 2036-02-05 | ⤷ Try it Free |
| GSK2982772 | Brazil | BR112018015410 | 2036-02-05 | ⤷ Try it Free |
| GSK2982772 | Canada | CA3012832 | 2036-02-05 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
